Please use this identifier to cite or link to this item:
|Title:||Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance-An Asian Perspective||Authors:||Ng, E.S.T.
|Issue Date:||2010||Citation:||Ng, E.S.T., Liew, Y., Koh, L.P., Hsu, L.Y. (2010). Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance-An Asian Perspective. Journal of the Formosan Medical Association 109 (9) : 624-631. ScholarBank@NUS Repository. https://doi.org/10.1016/S0929-6646(10)60102-7||Abstract:||Febrile neutropenia remains a major cause of morbidity and mortality in patients receiving chemotherapy. Major prophylactic strategies include granulocyte colony-stimulating factor and antibiotics, the most widely used of which are fluoroquinolones. While fluoroquinolone prophylaxis has been shown to be effective in areas where fluoroquinolone resistance is low, this same efficacy has not been proven in areas where resistance is high, such as in Asia. Given the increase in antimicrobial resistance with the use of prophylaxis, the risks and benefits of this strategy need to be carefully considered. This review presents the evidence for and against fluoroquinolone prophylaxis in areas of high fluoroquinolone resistance. © 2010 Formosan Medical Association & Elsevier.||Source Title:||Journal of the Formosan Medical Association||URI:||http://scholarbank.nus.edu.sg/handle/10635/126923||ISSN:||09296646||DOI:||10.1016/S0929-6646(10)60102-7|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 14, 2019
WEB OF SCIENCETM
checked on Jun 7, 2019
checked on May 24, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.